Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Bravi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drugs|April 11, 2019
Are All Dopamine Agonists Essentially the Same?Margherita Torti, Daniele Bravi, Laura Vacca, et al.
Nature Reviews. Neurology|November 4, 2024
Parkinson disease therapy: current strategies and future research prioritiesFabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 16, 2018
Disease progression in Parkinson subtypes: the PPMI datasetDarko Aleksovski, Dragana Miljkovic, Daniele Bravi, et al.
Expert Opinion on Investigational Drugs|May 19, 2020
Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trialsAngelo Antonini, Daniele Bravi, Michele Sandre, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 4, 2021
Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot studyLaura Vacca, Stefania Proietti, Daniele Bravi, et al.
Current Neuropharmacology|June 3, 2025
Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety StudyFabrizio Stocchi, Daniele Bravi, Fabiana Giada Radicati, et al.
Psychopharmacology|July 24, 2010
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindoleFelice Iasevoli, Carmine Tomasetti, Federica Marmo, et al.
European Journal of Pharmacology|January 5, 2002
Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2)Daniela Uberti, Laura Piccioni, Anna Colzi, et al.
Brain Research. Molecular Brain Research|February 9, 2002
Acute administration of antipsychotics modulates Homer striatal gene expression differentiallyAndrea de Bartolomeis, Luigi Aloj, Alberto Ambesi-Impiombato, et al.
British Journal of Clinical Pharmacology|August 6, 2019
Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)Margherita Torti, Jhessica Alessandroni, Daniele Bravi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drugs|April 11, 2019
Are All Dopamine Agonists Essentially the Same?Margherita Torti, Daniele Bravi, Laura Vacca, et al.
Nature Reviews. Neurology|November 4, 2024
Parkinson disease therapy: current strategies and future research prioritiesFabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 16, 2018
Disease progression in Parkinson subtypes: the PPMI datasetDarko Aleksovski, Dragana Miljkovic, Daniele Bravi, et al.
Expert Opinion on Investigational Drugs|May 19, 2020
Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trialsAngelo Antonini, Daniele Bravi, Michele Sandre, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 4, 2021
Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot studyLaura Vacca, Stefania Proietti, Daniele Bravi, et al.
Current Neuropharmacology|June 3, 2025
Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety StudyFabrizio Stocchi, Daniele Bravi, Fabiana Giada Radicati, et al.
Psychopharmacology|July 24, 2010
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindoleFelice Iasevoli, Carmine Tomasetti, Federica Marmo, et al.
European Journal of Pharmacology|January 5, 2002
Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2)Daniela Uberti, Laura Piccioni, Anna Colzi, et al.
Brain Research. Molecular Brain Research|February 9, 2002
Acute administration of antipsychotics modulates Homer striatal gene expression differentiallyAndrea de Bartolomeis, Luigi Aloj, Alberto Ambesi-Impiombato, et al.
British Journal of Clinical Pharmacology|August 6, 2019
Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)Margherita Torti, Jhessica Alessandroni, Daniele Bravi, et al.
Pageof 2